ArticleMolecular imaging and biology2024
Translational Potential of a Contrast Agent for FGS Applications in pNETs.
Solmaz AghaAmiri, Jeannelyn S Estrella, Servando Hernandez Vargas, Mark W Hurd, Sukhen C Ghosh, Ali Azhdarinia, Naruhiko Ikoma
Abstract read
In one paragraphArticle in Molecular imaging and biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Solmaz AghaAmiriThe Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, 77054, USA.
Jeannelyn S EstrellaDepartment of Anatomic Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Servando Hernandez VargasThe Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, 77054, USA.
Mark W HurdSheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Sukhen C GhoshThe Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, 77054, USA.
Ali AzhdariniaThe Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, 77054, USA. ali.azhdarinia@uth.tmc.edu.ORCID 0000-0001-8000-907X Naruhiko IkomaDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. nikoma@mdanderson.org.
Funding
Receptor-Targeted Fluorescence-Guided Surgery in Pancreatic Neuroendocrine TumorsR01CA263512 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Ali Azhdarinia, Naruhiko Ikoma · 2022 to 2026
$2.3MNCI NIH HHS R01 CA263512NIH HHS R01 CA263512-01A1
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Neuroectodermal Tumors, PrimitiveNeuroendocrine TumorsPancreatic NeoplasmsContrast MediaHumansRetrospective StudiesContrast MediaFGSNeuroendocrine tumorspNETSSTR2
Identifiers
PMID38267640
PMCPMC10973013
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390